Mental Health Clinics in Sunrise, FL Accepting Medicare
87 Mental Health Clinics found. Showing 81 - 87
 J.p.a. Counseling, Inc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9781 Sunrise Lakes Blvd Apt 210, Sunrise, FL 33322 Phone: 954-295-9911 |
Smith Mental Health Assoc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4265 N Pine Island Rd, Sunrise, FL 33351 Phone: 954-415-6140 |
Vital Skills Center Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 4117 N Pine Island Rd, Sunrise, FL 33351 Phone: 954-652-8613 |
Mhns Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 14201 W Sunrise Blvd Ste 208, Sunrise, FL 33323 Phone: 954-282-9856 |
Michelle R Demenkow, Pa Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 14201 W Sunrise Blvd Ste 208, Sunrise, FL 33323 Phone: 954-851-9690 Fax: 954-366-5056 |
Rejuvenate Minds Counseling Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2868 Nw 80th Ave, Sunrise, FL 33322 Phone: 954-507-7219 |
Road To Mindfulness Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 11441 Nw 35th Pl, Sunrise, FL 33323 Phone: 860-287-4292 |
News Archive
Positive data from Tetraphase Pharmaceuticals' eravacycline Phase 2 trial on cIAI
Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing novel antibiotics effective against antibiotic-resistant bacteria, presented new, positive Phase 2 clinical data on its lead drug candidate, eravacycline (TP-434), on September 11, 2012, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Study uncovers why elderly people struggle to swallow
A new study has revealed people naturally lose muscle and function in the throat as they age, making it harder for food to move from the mouth to the space above the food pipe.
Studies find patients often choose higher cost treatments, doctor-patient communications needs improvement
The studies in JAMA Internal Medicine look at issues surrounding coordinated care between doctors and their patients.
New way to more efficiently deliver CRISPR/Cas9 therapeutic to mice with Tyrosinemia type I
University of Massachusetts Medical School researchers have found a way to more efficiently delivery a CRISPR/Cas9 therapeutic to adult mice with the metabolic disease Tyrosinemia type I that may also prove to be safer for use in humans.
› Verified 4 days ago